BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3084301)

  • 1. Danazol inhibits steroidogenesis by the human ovary in vivo.
    Steingold KA; Lu JK; Judd HL; Meldrum DR
    Fertil Steril; 1986 May; 45(5):649-54. PubMed ID: 3084301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Danazol: endocrine consequences in healthy women.
    Luciano AA; Hauser KS; Chapler FK; Sherman BM
    Am J Obstet Gynecol; 1981 Nov; 141(6):723-7. PubMed ID: 6797301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of danazol on gonadal steroidogenesis in patients with a complete form of testicular feminization.
    Reyniak JV; Gurpide E
    Am J Obstet Gynecol; 1982 Feb; 142(4):479-81. PubMed ID: 6800258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women.
    Rannevik G; Thorell JI
    Acta Obstet Gynecol Scand Suppl; 1984; 123():89-94. PubMed ID: 6437127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of effect of danazol on estrogen-induced luteinizing hormone release from rat hypothalamo-pituitary axis in vitro.
    Miyake A; Tasaka K; Aono T
    Contraception; 1983 Jul; 28(1):87-91. PubMed ID: 6627947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypothalamic-pituitary-ovarian axis in patients with endometriosis is suppressed by leuprolide acetate but not by danazol.
    Sakata M; Ohtsuka S; Kurachi H; Miyake A; Terakawa N; Tanizawa O
    Fertil Steril; 1994 Mar; 61(3):432-7. PubMed ID: 8137962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danazol: endocrine pharmacology and therapeutic applications.
    Barbieri RL; Ryan KJ
    Am J Obstet Gynecol; 1981 Oct; 141(4):453-63. PubMed ID: 7025640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hormonal effect of danazol in women with regular menstrual cycles and in those with ovarian deficiency].
    Bertaglia MG; Miragoli A; Dorato F; Nencioni T
    Ann Ostet Ginecol Med Perinat; 1980; 101(3):173-80. PubMed ID: 6779692
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of danazol treatment during the luteal phase on pituitary and ovarian function during the subsequent menstrual cycle.
    Fraser IS; Markham R; Robinson M; Thorburn GD
    Fertil Steril; 1982 Apr; 37(4):489-93. PubMed ID: 6802677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestational activity of danazol in the human female subject.
    Wentz AC; Jones GS; Sapp KC; King TM
    Am J Obstet Gynecol; 1976 Oct; 126(3):378-84. PubMed ID: 961786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danazol suppression of gonadal estradiol-17 beta secretion--report of two sibling cases with a complete form of testicular feminization on gonadal ultrastructure and endocrine status.
    Yoshida K; Utsunomiya T; Kadota T; Yamaguchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):133-41. PubMed ID: 6421963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic tests of hypothalamic and pituitary function in women treated with danazol.
    Fraser IS; Markham R; McIlveen J; Robinson M
    Fertil Steril; 1982 Apr; 37(4):484-8. PubMed ID: 6802676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine effects of danazol in menstruating women.
    Guillebaud J; Fraser IS; Thorburn GD; Jenken G
    J Int Med Res; 1977; 5 Suppl 3():57-66. PubMed ID: 913882
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the pharmacology of nafarelin and danazol.
    Barbieri RL
    Am J Obstet Gynecol; 1990 Feb; 162(2):581-5. PubMed ID: 2137975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danazol inhibits steroidogenesis.
    Barbieri RL; Canick JA; Makris A; Todd RB; Davies IJ; Ryan KJ
    Fertil Steril; 1977 Aug; 28(8):809-13. PubMed ID: 885271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of danazol on serum concentrations of pituitary gonadotropins in postmenopausal women.
    Döberl A; Jeppsson S; Rannevik G
    Acta Obstet Gynecol Scand Suppl; 1984; 123():95-8. PubMed ID: 6437128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and clinical effects of danazol.
    Dmowski WP
    Am J Obstet Gynecol; 1982 Jul; 143(6):726-9. PubMed ID: 7091253
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women.
    Dmowski WP; Headley S; Radwanska E
    Fertil Steril; 1983 Jan; 39(1):49-55. PubMed ID: 6401252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exogenous conjugated estrogen on plasma gonadotropins and ovarian steroids during the menstrual cycle.
    Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
    Obstet Gynecol; 1974 May; 43(5):676-84. PubMed ID: 4362727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.